Avery Dennison Medical, Ltd.

Avery Dennison Medical, Ltd. specializes in surgical incise drapes infused with chlorhexidine gluconate (CHG) antimicrobial solution. These products are designed to help reduce surgical site infections during medical procedures by providing an antimicrobial barrier.

The company is headquartered in the United States. While the exact location isn’t specified, its regulatory filings and operations are conducted from within the U.S., aligning with its manufacturing focus on FDA-regulated medical devices.

The company’s devices, such as surgical incise drapes with antimicrobial properties, are classified as Class II medical devices under U.S. regulations. This classification applies because the products pose moderate risk and require special controls to ensure safety and effectiveness, such as antimicrobial efficacy testing and labeling requirements.

Avery Dennison Medical, Ltd.’s devices are listed in the FDA 510(k) database, which tracks Class II medical devices that have undergone premarket notification clearance in the U.S. This registry confirms the devices meet FDA requirements for safety and performance before commercial distribution.